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Efficient transfection of DNA or shRNA vectors into neurons
using magnetofection
Abstract
Efficient and long-lasting transfection of primary neurons is an essential tool to address many questions
in current neuroscience using functional gene analysis. Neurons are sensitive to cytotoxicity and
difficult to transfect with most methods. We provide a protocol for transfection of cDNA and RNA
interference (shRNA) vectors, using magnetofection, into rat hippocampal neurons (E18/19) cultured for
several hours to 21 days in vitro. This protocol even allows for double-transfection of DNA into a small
subpopulation of hippocampal neurons (GABAergic interneurons), as well as achieving long-lasting
expression of DNA and shRNA constructs without interfering with neuronal differentiation. The
protocol, which uses inexpensive equipment and reagents, takes 1 h, utilizes mixed hippocampal
cultures, a transfection reagent, CombiMag and a magnetic plate, shows low toxicity and is suited for
single cell analysis. Modifications as done by our three laboratories are detailed.
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Efficient and long-lasting transfection of primary neurons is an essential tool for addressing many questions in current neuroscience
using functional gene analysis. Neurons are sensitive to cytotoxicity and difficult to transfect with most methods. We provide a
protocol for transfection of cDNA and RNA interference (short hairpin RNA (shRNA)) vectors, using magnetofection, into rat
hippocampal neurons (embryonic day 18/19) cultured for several hours to 21 d in vitro. This protocol even allows double-transfection
of DNA into a small subpopulation of hippocampal neurons (GABAergic interneurons), as well as achieving long-lasting expression of
DNA and shRNA constructs without interfering with neuronal differentiation. This protocol, which uses inexpensive equipment and
reagents, takes 1 h; utilizes mixed hippocampal cultures, a transfection reagent, CombiMag, and a magnetic plate; shows low toxicity
and is suited for single-cell analysis. Modifications done by our three laboratories are detailed.
INTRODUCTION
Every gene transfer method aims to achieve high transfection
efficiency, low toxicity and long-lasting expression. These goals
are especially difficult to achieve for postmitotic primary neurons
due to their high sensitivity to any microenvironmental
change1–5. Many currently available transfection methods do not
yield sufficiently good gene expression results to allow functional
gene analysis in differentiated adherent neurons in vitro. A recent
report provides a useful overview of seven different gene
delivery methods, including two often-used transfection tech-
niques (calcium-phosphate and lipofection), but excluding
magnetofection6.
Magnetofection is a technique that can be used to reliably and
efficiently introduce DNA into a variety of cell types7. Therefore, we
have invested in designing a reliable, magnetofection-based proto-
col to express DNA or shRNA constructs in rat hippocampal
neurons (embryonic day (E)18/19) cultured for several hours to
21 d in vitro (DIV). After transfection, neurons expressing exogen-
ous proteins can develop normally in culture for 5–10 d. We have
determined the optimum parameters for transfection efficiency
such as age of cells at transfection time point, expression levels
during the time after transfection and parameters for double-
transfection. This protocol shows low toxicity, uses a combination
of a transfection reagent, CombiMag, and magnetic force and
shows a sufficiently high efficiency in neurons (ca. 5%) to allow
single-cell analysis.
We present a core protocol and illustrate the critical steps,
modifications and applications carried out by our three labora-
tories (Medina, Fuhrer and Fritschy)8–10. This protocol allows
single and double transfections of DNA vectors at different time
points after plating. First, we present a detailed characterization of
magnetofection parameters such as age of neurons, time course of
protein expression after magnetofection, and transfection efficiency
in pyramidal neurons and GABAergic interneurons. Three specific
applications are then demonstrated. In the first application, expres-
sion of the synaptic scaffold protein gephyrin11 was compared
after early and late transfection. The slow development of
GABAergic synapses proceeded normally under these circum-
stances, showing that gephyrin-GFP expression did not interfere
with neural development and synapse formation. In the second
application, we concentrated on two genes, a7 nicotinic acetyl-
choline receptor and the scaffold protein PICK110. We achieved
simultaneous expression of these two genes in GABAergic inter-
neurons, which form a small subset of cells. This is quite an
achievement, considering how hard neurons are to transfect with
most methods. In the third application, long-lasting expression
of shRNAs against the synaptic GTPase activating protein
(SynGAP)12,13 was optimized. We achieved long-lasting decrease of
the expression of SynGAP in neurons for up to 6 d. These three
applications were successful by bringing about small variations in
the cell culture and magnetofection protocol, which are mainly
determined by the time point of transfection relative to plating
(see Methods A–C in Table 1).
In comparison with the seven recently reviewed methods of gene
delivery6, we note the following advantages of our magnetofection
protocol. First, the method is cost-effective, requires no expensive
equipment, is easy to perform, takes only 1 h and does not depend
on preparation of complex constructs such as viruses. Second, it is
not toxic for neurons, is used on young as well as mature neurons
and allows long-term gene expression. Other methods are prefer-
entially used for young neurons (e.g., 4 DIV14), which are generally
much easier to transfect than mature neurons, or, in the case of
electroporation and nucleofection6, only for cells in suspension at
the time of plating. Third, we achieve expression of two mamma-
lian proteins, not only GFP (which is comparatively easy to
express), in the same neuron. Most of the other protocols con-
centrate on only one gene, or one mammalian gene in combination
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with GFP1. Fourth, the overall efficiency of our method is compar-
able to the recently reviewed calcium-phosphate and lipofection
methods6. However, we achieve expression of two mammalian
genes in a small subpopulation of cells, the GABAergic interneur-
ons. This shows that even small neuronal cell subpools are unlikely
to be excluded from gene expression in our approach.
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TABLE 1 | Overview of cell culture conditions, media and concentrations of reagents used, depending on preferred magnetofection time point and
as done by the three laboratories (A, Fuhrer and Fritschy laboratories; B, Fritschy and Medina laboratories; C, Medina laboratory).
Method A B C
Cell culture before
magnetofection
Culture dish 18 mm coverslip in a 12-well
plate
35 mm dish (containing 3  14 mm coverslip)
Transfection time point o13 DIV o10 DIV 414 DIV; also possible on
younger neurons
Protein expression Short-term Short-term; long-term
expression is possible in
young neurons
Short-term or long-term
Number of cells 50,000 400,000–800,000 800,000–1,200,000
Volume of plating
media (adhering step)
200 ml per coverslip  
Culture media MEM supplemented with 15%
Nu-serum, 2% B27, 15 mM
HEPES (pH 7.2), 0.45% glucose,
1 mM sodium pyruvate, 2 mM
L-glutamine and 10 IU ml1
penicillin–streptomycin
MEM supplemented with
10% Nu-serum, 15 mM HEPES
(pH 7.2), 0.45% glucose,
1 mM sodium pyruvate, 2 mM
L-glutamine and 10 IU ml1
penicillin–streptomycin
Until 4 DIV, MEM supplemented
with 10% Nu-serum, 15 mM
HEPES (pH 7.2), 0.45% glucose,
1 mM sodium pyruvate, 2 mM
L-glutamine and 10 IU ml1
penicillin–streptomycin was
used
Media volume 2 ml per well in a 12-well plate 2 ml per 35 mm dish
Feeding media Culture medium remains, no
media exchange
Culture medium remains,
no media exchange
From 5 DIV, gradual exchange
of the culture medium with a
feeding medium (MEM supple-
mented with 2% B27, 15 mM
HEPES, 0.45% glucose, 1 mM
sodium pyruvate and 2 mM
L-glutamine). Exchange 50%
of medium with fresh feeding
medium; repeat every third day
and the day before transfection
Magnetofection DNA (A) 1 mg in 30 ml OptiMEM 0.8 mg in 150 ml OptiMEM
Lipofectamine
2000 (B)
2 ml in 30 ml OptiMEM 7 ml in 150 ml OptiMEM
Incubate for 5 min at room temperature; combine (A) and (B)
CombiMag 2 ml, 1:10 dilution in H2O 1 ml, undiluted
Add CombiMag, mix and incubate for 15 min at room temperature
Cells Remove 50% medium
and save it; leave 1 ml
in each well
Leave media
Carefully add transfection complex to cells
Incubate cells on magnetic plate at 37 1C, 5% CO2 for 25 min
Media change Replace by saved medium Replace 80% by feeding media
Assay Perform assay earliest after 6 h
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MATERIALS
REAGENTS
.One timed-mated rat (Wistar) ! CAUTION All experiments using live rodents
should conform to local and national regulations.
.PBS (Gibco, 18912-014)
.Minimum essential medium (MEM; Invitrogen, 31095-052)
.Dulbecco’s modified Eagle’s medium (DMEM; Gibco, 61965-026)
.Nu-serum (Becton Dickinson, 355500)
.B27 supplement (Invitrogen, 17504044)
.FCS (Gibco, 10270-106)
.BSA (Sigma, A-9418)
.Papain (Sigma, P-4762)
.DNase I (Sigma, DN25)
.Glucose monohydrate (Mw 198.7 Da)
.1 mM sodium pyruvate (Invitrogen, 11360-039)
.1 M HEPES (Invitrogen, 15630056)
.2 mM L-glutamine (Gibco, 25030-24)
.10 IU ml1 penicillin–streptomycin (Gibco, 15140-122)
.OptiMEM (Invitrogen, 31985-070)
.CombiMag 100 (OZ Biosciences, CM20100)
.Lipofectamine 2000 (Invitrogen, 11668-019)
.Poly-L-lysine (Sigma, P-1520)
.DNA constructs (generated according to standard molecular biology
techniques, those we used are in Box 1)
.Endo-free Maxi prep purification kit (Qiagen, 12262)
.0.25% trypsin (wt/vol; Gibco, 25090-028)
.45% D-glucose (wt/vol; Sigma, G-8769)
EQUIPMENT
.Standard cell culture equipment (laminar flow hood, dissecting tools,
incubators, hoods, centrifuges, water baths, fridge and freezers)
.Molecular biology equipment (fridge, freezers, oven, sonicator, centrifuges,
pipettes, plastic ware, tips and glassware)
.Magnetofection apparatus including super magnetic plate (OZ Biosciences,
10000)
.18 mm glass coverslips coated with poly-L-lysine (Menzel)
.14 mm microscope coverslips (Marienfeld GmbH & Co, VWR 0111520)
.12-well tissue culture plates (NUNC or Greiner)
.15 ml Falcon tubes
.Pasteur pipettes
.Neubauer counting chamber of 0.1 mm depth, 0.0025 mm2 (Optik Labor)
. Inverted fluorescence microscope equipped with long-distance air objective
(10 or 20 lens)
.Epifluorescence microscope with objective lenses (e.g., Axioskop 2 or
ApoTome, Carl Zeiss AG)
REAGENT SETUP
Culture medium For Method A, use MEM supplemented with 15% (vol/vol)
Nu-serum, 2% (vol/vol) B27, 0.015 M HEPES (pH 7.2), 0.45% (wt/vol)
D-glucose, 1 mM sodium pyruvate, 2 mM L-glutamine and 10 IU ml1
penicillin–streptomycin. For Methods B and C, use MEM supplemented
with 10% (vol/vol) Nu-serum, 15 mM HEPES (pH 7.2), 0.45% (wt/vol)
D-glucose, 1 mM sodium pyruvate, 2 mM L-glutamine and 10 IU ml1
penicillin–streptomycin. See Table 1.
Feeding medium For Method C, use MEM supplemented with 15 mM
HEPES, 0.45% (wt/vol) D-glucose, 1 mM sodium pyruvate, 2 mM L-glutamine
and 2% (vol/vol) B27. See Table 1.
Borate buffer 0.15 M boric acid, pH 8.4.
Papain solution PBS with 10 mM glucose containing 0.05% (wt/vol) papain
and 0.1% (wt/vol) BSA.
Dissection solution PBS with 0.25% (wt/vol) D-glucose.
PROCEDURE
Preparation of glass coverslips
1| Dissolve poly-L-lysine stock in water to obtain a 1 mg ml1 solution, distribute in 1 ml aliquots and store at 20 1C.
2| Prepare cover glasses as follows. Place coverslips into a 200 ml flask with narrow neck. Shake them overnight in 1%
(vol/vol) nitric acid. Rinse the coverslips thoroughly (shake for at least 3 h in tap water; change water every 20–30 min).
Sonicate coverslips three times for 30 min (using, e.g., Fisher ultrasonic cleaner 15-335-140) in distilled water, then three
times in 70% (vol/vol) ethyl alcohol and, finally, two times in 95% (vol/vol) ethyl alcohol. Place the washed coverslips in
a glass Petri dish and sterilize at 160 1C for 1 h.
’ PAUSE POINT Pre-washed sterile coverslips can be stored at room temperature (B20 1C) for a few months.
3| Coat cover glasses with poly-L-lysine: Dissolve the stock of poly-L-lysine in distilled water or borate buffer (1:100),
filter and apply to culture dishes with coverslips. Incubate overnight at 37 1C. Rinse with PBS at least three times.
m CRITICAL STEP Such rigorous procedures of washing and coating of coverslips are critical for neuron culturing. Insufficient
washes of coverslips before coating and/or shortening of the time of coating will result in neuron clustering and suboptimal
cultures. Residual poly-L-lysine (insufficient washing) is toxic for neurons.
’ PAUSE POINT Dissolved poly-L-lysine can be stored at 4 1C for up to 1 month.
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BOX 1 | DNA CONSTRUCTS
The DNA constructs used in our applications were the following:
(i) pEGFP (Clontech 6077-1)
(ii) Full-length gephyrin derived from pcDNA3-based constructs23, PCR-cloned into the EcoRI/SalI site of pEGFP–C2 (Clontech; a gift from
Dr. Gu¨nter Schwarz, University of Cologne)
(iii) C-terminally Flag-tagged mouse a7 nAChR in pCS2+ expression vector (a gift from Dr. Ines Ibanez-Tallon, MDC Berlin-Buch)
(iv) N-terminally EYFP-tagged rat PICK1 in pRK5 expression vector (PICK1-EYFP) and the empty control EYFP vector (a gift from Prof. Ann Marie
Craig and Dr. Fernanda Laezza, Washington University24)
(v) SynGAP shRNA created by insertion of the following oligonucleotides into the Hpa1/Xho1 sites of the Lentilox 3.7 vector (ATCC; no
VRMC-39)21,22:
5¢-TGAAGCGATATTACTGCGAGTTCAAGAGAAACTCGCAGTAATATCGCTTCTTTTTTC-3¢
5¢-TCGAGAAAAAAGAAGCGATATTACTGCGAGTTTCTCTTGAACTCGCAGTAATATCGCTTCA-3¢
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Preparation of solutions
4| Dissolve DNase in distilled water to obtain a 10 mg ml1 solution; filter and store at 20 1C in 0.3 ml aliquots.
5| Prepare fresh dissection solution and keep at 4 1C.
6| Prepare papain solution and pre-incubate at 37 1C. Before use, add 0.01 mg ml1 DNase I and sterilize by filtration.
7| Prepare culture medium according to Table 1 (Methods A–C).
m CRITICAL STEP Always prepare fresh culture medium.
8| Prepare feeding medium if necessary according to Table 1.
m CRITICAL STEP Feeding medium does not contain any Nu-serum or antibiotics. Feeding medium can be stored at 4 1C for up to
1 week.
Culturing cell type of interest
9| Prepare the cell type of interest. This protocol describes the use of rat E18–19 hippocampal neurons. Harvest E18–19
hippocampi and dissect the hippocampi free of meninges in cooled (2–3 1C) dissection solution.
m CRITICAL STEP It is essential to remove all the meninges from the hippocampi.
m CRITICAL STEP The temperature of the dissection solution is critical; it should not be more than 2–3 1C.
m CRITICAL STEP Optimization of neuronal cultures is an essential requirement for the success of this method. The key point
to be noted is that glia–neuron coculture using defined medium has to be used, and not Banker type cultures nor glia feeder layer
(in Banker cultures, neurons are separated from a glia feeder layer but are immersed in the same medium, which has a different
composition than ours15,16). All our attempts to modify this protocol gave negative results. Also, we failed to transfect neurons
prepared using other protocols, particularly those grown in neurobasal media.
m CRITICAL STEP In our experience, the batch of Nu-serum varied, so it is essential to do a titration experiment with different Nu-
serum concentrations (e.g., 10%, 15%, 20% (all vol/vol)).
10| Incubate hippocampi with papain solution for 15 min at 37 1C; gently shake every 5 min. For example, we routinely use
10–20 hippocampi in 5 ml of solution in one 15 ml Falcon tube.
m CRITICAL STEP You can replace papain with trypsin (final concentration 0.25%), as both give similar results. The critical point is
the time of incubation.
11| Stop the papain reaction by washing twice with DMEM and then resuspend in a final volume of 1 ml of DMEM/FCS
(10% vol/vol).
12| Triturate the tissue using a fire-polished Pasteur pipette ten times. Transfer the dissociated cells into a new tube.
! CAUTION We recommend gentle trituration of the tissue for exactly 10 times. The diameter of the fire-polished Pasteur pipette
should be adjusted to result in single-cell dissociation without rupturing the cells by turbulences.
13| Calculate the number of neurons using a Neubauer plate. Place a 10 ml sample of the cell suspension onto the Neubauer plate
and cover it with a cover glass. Capillary action completely fills the chamber with the sample. Count the cells in an area of 1 mm2
(equals a volume of 100 nl) using a microscope. Multiplying the number of counted cells by 104 gives the number of cells per milliliter.
14| Dilute the dissociated neurons to the desired concentration with culture medium. Plate cells at a density according to
Table 1. In Method A, the plating volume is 200 ml per coverslip with 50,000 cells. In Methods B and C, dilute the cell
suspension to a desired concentration (200,000–600,000 cells per ml) and directly apply 2 ml of suspension to the 35 mm dish.
! CAUTION We recommend optimization of the number of cells relative to the dish/coverslip used. Usually from ten embryos,
we prepare 20–25 culture dishes (35 mm).
15| Let the cells adhere to the coverslip for 1 h at 5% CO2/37 1C. If using 18 mm coverslips in 12-well plates (Method A,
Table 1), transfer the coverslip to the 12-well tissue culture plate and add 2 ml of culture medium per well; in our experience,
more medium is toxic to cells. This step is not required for 35 mm dishes.
16| Grow the cells at 5% CO2 and 37 1C, until the desired time point for transfection.
m CRITICAL STEP Optimal neuronal growth before magnetofection is a key parameter for successful experiments. It depends on the
initial cell density, pH of the culture medium (7.2; verify that the incubator has the correct %CO2 settings) and medium
supplementation with Nu-serum and B27. In particular, problems with astrocyte overgrowth can be solved by varying the
concentration of Nu-serum.
m CRITICAL STEP In good-quality cultures, neurons are equally distributed throughout the dish or coverslip during the whole
period of culturing. Aggregation of neurons in clusters after 7–10 DIV markedly affects transfection efficacy. Also, neurons growing
in clusters might have different properties (synapse density) as compared to neurons growing as a monolayer.
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m CRITICAL STEP For short-term transfection of mature neurons (10–12 DIV; Method A in Table 1), the initial cell density is
relatively low and addition of B27 to the culture medium is required to stimulate neuronal growth. We recommend leaving the cells in
the same culture medium for the entire time from before magnetofection up to 12 DIV. In our experience, the cells suffer from
repeated medium changes.
m CRITICAL STEP Specific comments for Methods B and C: for magnetofection of immature neurons (6 DIV; Method B in Table 1),
it is better to start with a density of 600,000 cells per 35 mm dish and without B27; if transfection is long-term (44 d), a feeding
medium containing B27 is required after transfection (Method C in Table 1); finally, for late magnetofection (414 DIV; Method C
in Table 1), a higher initial cell density is necessary (800,000 cells per 35 mm dish), and the culture medium is replaced
gradually with a feeding medium containing B27. Start feeding the neurons at 5 DIV and change 50% of the medium every 3 d.
Twenty-four hours before transfection, replace 50% of the culture medium with fresh medium.
m CRITICAL STEP Best results with Methods B and C are obtained by growing cells on 14 mm coverslips placed in 35 mm
plastic dishes. Place these culture dishes into a larger (150 mm) Petri dish to prevent evaporation of the culture medium.
Incubate cultures in the CO2 (5%) incubator at 37 1C.
? TROUBLESHOOTING
Magnetofection procedure
17| Prepare or obtain DNA constructs of interest.
m CRITICAL STEP The use of high-quality DNA obtained with Maxi prep kits and additional purification with phenol/chloroform
improves transfection efficacy.
18| Prepare transfection mixture. The following procedure applies for both cDNA and shRNA vectors. First combine DNA and
OptiMEM in one Eppendorf tube (solution A). Different concentrations of reagents are required for Method A and for Methods B
and C (see Table 1).
m CRITICAL STEP Double-magnetofection can be difficult; do not exceed a total of 1 mg DNA, as it considerably decreases the rate
of transfection.
19| Combine lipofectamine 2000 and OptiMEM according to Table 1 in a second Eppendorf tube (solution B), mix gently and
incubate solutions A and B for 5 min at room temperature (20 1C).
20| Combine solutions A and B.
21| For 18 mm coverslips, dilute CombiMag in H2O (1:10) and vortex the diluted solution; for 35 mm dishes, use undiluted
CombiMag solution and vortex (see Table 1).
m CRITICAL STEP You can keep the diluted CombiMag solution for up to 1 month at 4 1C, but we do not recommend use of older
solutions.
22| Add CombiMag solution to the combined solutions A and B (CombiMag–DNA–lipofectamine 2000), mix and incubate for
15 min at room temperature (see Table 1).
m CRITICAL STEP Gently handle the DNA transfection complex.
23| For 18 mm coverslips (Method A, Table 1), take the
12-well dish containing cultured neurons out of the incubator and remove half of the culture medium. Leave 1 ml per well.
Store the removed medium.
m CRITICAL STEP Ensure that the cultured neurons are on the top of the coverslip.
24| Carefully add CombiMag–DNA–lipofectamine 2000 complex dropwise to cells.
25| Incubate cells on a pre-warmed magnetic plate at 37 1C for a minimum of 25 min.
m CRITICAL STEP The transfection time on the magnetic plate is a critical point. In our experience, longer transfection time results
in higher transfection efficiency, but often higher toxicity.
m CRITICAL STEP Transfection efficiency is dependent on the plasmid backbone.
26| Replace the medium including CombiMag–DNA–lipofectamine 2000 complex (see Table 1).
m CRITICAL STEP In immature neuronal cultures (o10 d), the entire medium can be replaced with saved pre-warmed culture
medium or feeding medium (never let neurons dry). In older neurons, complete removal of the medium will damage neurons.
To avoid this, we change 80% of the medium.
m CRITICAL STEP For some constructs, protein expression could be optimized by decreasing the incubator temperature to 32 1C.
? TROUBLESHOOTING
27| Transfer the cells to the incubator for at least 6 h.
? TROUBLESHOOTING
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Assay and analysis
28| Perform assay and analysis (immunocytochemistry, electrophysiology or image analysis) according to your experimental
setup, at the earliest 6 h after transfection. We routinely perform immunocytochemistry and capture images using epifluorescence
microscopy (Axioskop 2 or ApoTome, Carl Zeiss AG) combined with a high-resolution digital camera (Hamamatsu Photonics) or
by confocal laser-scanning microscopy (TCS 4D; Leica; Fluorview 500, Olympus). Collect high-resolution confocal laser-scanning
microscope images (63 or 100 oil immersion objective) of neurons, fluorescently double-labeled for the proteins of interest.
Contrast-optimize these images using imaging software (e.g., using Adobe Photoshop, Adobe Systems Inc.). Perform quantitative
analysis using imaging software, keeping constant threshold levels (e.g., using ImageJ, NIH; or Metamorph).
 TIMING
Steps 1–3, preparation of glass coverslips: 1 d
Steps 4–8, preparation of solutions: 1–2 h
Steps 9–16, culturing cell type of interest: 8 h–21 d
Steps 17–27, magnetofection procedure: 1 h
Step 28, assay and analysis: 12 h–14 d
? TROUBLESHOOTING
Troubleshooting advice can be found in Table 2.
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TABLE 2 | Troubleshooting table.
Step Problem Possible reason Solutions and suggestions
16 Neuronal cultures show
unhealthy morphology
Suboptimal culturing conditions Essential requirements: optimization of primary neuronal
cultures from hippocampus and cortex. Key points:
control CO2 and pH, control Nu-serum concentration,
regularly verify the CO2 settings of the incubator
Too many glial cells/few
neurons in the culture
Suboptimal culturing conditions Vary the amount of Nu-serum (neurons tolerate an
increase up to 20% in Method A)
Neurons in culture form
clusters
Appearance of clusters of neurons after 6–10
DIV indicates (i) inefficient coverslip coverage
with poly-L-lysine, (ii) insufficient washing
of coverslips, (iii) inappropriate glass quality
for neuronal cultures
The simplest way to identify the cause of neuronal
cluster appearance is to verify the culture quality
growing on the plastic between coverslips. If the culture
is homogeneous, it is necessary to prepare a new batch
of coverslips
Coat the coverslips carefully with poly-L-lysine
Wash the coverslips properly during preparation
(Steps 2 and 3)
Use coverslip of some other manufacturer
26 Low magnetofection
efficiency of neurons
Suboptimal age of cells at magnetofection
time point, suboptimal culturing medium,
suboptimal DNA concentration, suboptimal DNA
construct, insufficient transfection efficiency
Optimizing the magnetofection parameters is a key
element to achieve high and stable magnetofection
rates and healthy neurons
The age of neurons at the magnetofection time point is
a very critical point. In our experience, hippocampal
cells cultured according to Method A are well magneto-
fectable until 11 DIV; afterward, the efficiency drops
The culturing medium plays an essential role in
achieving high magnetofection rates
Use fresh reagents
DNA constructs show varying success rates in
magnetofection efficiency. Try pEGFP construct
from Clontech as a control
For every culture type and after changing culturing
conditions (new batches of MEM, Nu-serum,
lipofectamine 2000, etc.), it is necessary to select
the optimal amount of DNA and lipofectamine
2000 used for magnetofection
Transfection efficiency depends also on the strength
of the magnetic field. Petri dishes are thinner than
12-well plates and might allow higher transfection rates
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ANTICIPATED RESULTS
We present, as examples, results from three independent groups showing that neuron transfection can be efficiently achieved
using magnetofection. We have successfully transfected a variety of DNA and shRNA constructs, most of which were enhanced
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TABLE 2 | Troubleshooting table (continued).
Step Problem Possible reason Solutions and suggestions
Toxicity of magnetofection
on neurons/survival rate
of neurons
Suboptimal DNA concentration We experienced that the DNA concentration as well
as the DNA construct itself has an influence on
magnetofection efficiency and toxicity
Low efficiency with double-
magnetofection procedure
For routine experiments, do not exceed a total of 1 mg
DNA. Do not incubate cells on pre-warmed magnetic
plate at 37 1C for longer than 25 min. Magnetofection
with 2 mg DNA for longer than 25 min will increase
transfection efficiency and also cell toxicity
27 Neurons die after
transfection
Usually, neuronal death after transfection is
related to medium change and not to toxicity
of reagents
We recommend ‘transfecting’ one dish by omitting DNA and
lipofectamine from the transfection mixture. If neurons
survive the medium change, but die in dishes with applied
reagents, decrease the volume of lipofectamine 2000
and/or take another preparation of DNA vector
After transfection, neurons
are alive but there are no
transfected cells
Transfect using the same protocol, confluent HEK293 cell
cultures with and without incubation step on magnetic
plate. The transfection efficacy should be at least 5%
after cell incubation without magnetic plate and 20%
with magnetic plate. Lower efficacy will suggest the
need to change lipofectamine 2000 or DNA
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Figure 1 | Expression of EGFP in neuronal cultures
(Method C). (a) Relative number of neurons
expressing EGFP at different times after
magnetofection at 9 DIV. All transfected neurons
were quantified on coverslips at different time
points in the same dishes, using a fluorescence
microscope equipped with CO2, camera and
temperature controller. Between acquisitions,
cultures were kept in the CO2 incubator. Data from
seven experiments are shown. (b) Number of
transfected neurons per 14 mm coverslip as
function of culture age. EGFP fluorescent neurons
were quantified 36 h after magnetofection.
(c) Images of the same fluorescent neurons
developing in culture. Images illustrate four
types of neurons that were transfected at DIV 9
and visualized 1, 3 and 5 d after transfection.
Neurons a and b showed relatively high level
of EGFP expression 24 h after magnetofection.
These neurons survived for 2.5 and 4.5 d after
magnetofection, respectively. Neuron c, which
showed weak and neuron d, which showed no
visible EGFP expression, at day 1 developed
normally for more than 5 d. (d) Longitudinal
analysis of neuronal survival in a typical
experiment. The left end of the bar is the time
when neurons first displayed EGFP fluorescence;
the right end indicates death of the neurons as
shown by their morphology. Neurons illustrated
in c are highlighted with color and marked using
corresponding letters. Similar results were
obtained in five additional experiments. Note
that 13 out of 31 transfected neurons survived
for more than 5 d.
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GFP (EGFP)-tagged for easy detection by fluorescence microscopy. This method is best suited for morphological or functional
analysis of single cells.
Transfection of mature neurons in culture is more difficult than transfecting immature neurons. Our method allows successful
magnetofection of neurons at different time points in culture, allowing to either study synaptic development in young neurons
(o10 DIV) or magnetofect mature cells (410 DIV), which have built up a synaptic network. Using different DNA or shRNA vectors
in mixed neuron–glia cocultures, we noticed that these constructs are efficiently expressed in neurons but not astrocytes.
Seeking an optimal method of gene expression, we also tested, in parallel with magnetofection, electroporation of hippocampal cul-
tures as well as the calcium-phosphate method of transfection, using established protocols17,18. We found that out of these three
approaches only magnetofection allowed efficient and highly reproducible transfection of our neuronal cultures at later stages of
development (10–21 DIV). We therefore concentrated our efforts on optimizing magnetofection. A recent publication reported
an improved calcium-phosphate approach that also allowed neuron transfection at later stages of development, although double-
transfection was not mentioned and the focus was on GFP1. Nevertheless, our magnetofection protocol remains an alternative, simple
and powerful technique of neuronal transfection that does not require complex manipulations with different incubators, coverslip
transfer, and use of blockers of N-methyl D-aspartate channels and does not deal with calcium-phosphate precipitate, a product that
can potentially modify calcium balance in developing neurons and influence phosphorylation processes, leading to cell death.
Optimized neuronal culture for magnetofection
We found that optimization of the neuronal culture medium is an essential requirement for a high magnetofection rate and
optimal neuronal development and survival. Key points to note are that we do not use Banker type cultures, nor glia feeder
layer; instead, we use a glia–neuron coculture with defined media. Depending on the magnetofection time point, optimal results
depended on appropriate cell density and medium composition, notably, the addition of B27 and the appropriate Nu-serum
concentration (see Table 1). B27 appears to be essential for long-term neuronal survival, whereas Nu-serum allows balancing
the density of neurons and astrocytes in mixed cultures. Further, the CO2 concentration and the pH of the medium are important
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c
Figure 2 | Demonstration of the efficiency of magnetofection using an EGFP construct and neurons cultured according to Method A. (a) DAPI labeling (red) shows
all cell nuclei, and DIC imaging was used to identify neurons. Approximately 20% of all cells are neurons. (b) The same cells shown in a are labeled with the marker
VGAT. Cells displaying a strong somatic staining and a punctuated staining on dendrites were identified as GABAergic interneurons (red arrows). Approximately
3% of all neurons are such interneurons. (c) EGFP labeling demonstrates the number of magnetofected neurons. Scale bars: (a,b) 100 mm; (c) 1 mm.
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parameters for achieving efficient
magnetofection. The three methods
presented need to be tested and
adjusted, based on the individual
results and experimental requirements.
Cell culture characterization and
magnetofection rates
Figure 1 shows experiments
investigating the efficacy of culture
transfection at different stages of
development and the kinetics of
exogenous protein (EGFP; Clontech vector
no. 6077-1) expression. To enable
comparison of transfections performed
at different stages, all experiments were
performed using Method C and on
nominally identical cultures (i.e., same
neuronal densities at plating and same
procedures of culture feeding). In all
cultures, the first fluorescent neurons
expressing GFP appeared 16 h after
magnetofection. The peak of EGFP
expression was reached 36 h after
magnetofection (Fig. 1a). Afterward, the
number of transfected neurons
progressively decreased; however, at least
5% of neurons transfected at 9 DIV
survived for more than 10 d (Fig. 1a).
Interestingly, long-time-surviving
neurons were neurons in which
detectable levels of EGFP expression
appeared only 48–72 h after
magnetofection (Fig. 1c,d). Most of the
neurons expressing high levels of the
exogenous protein 16–24 h after
transfection disappeared within 2–3 d.
Taken together, this suggests that the
disappearance (death) of transfected neurons was rather related to neuron exhaustion promoted by extensive protein synthesis than
to toxicity of GFP itself.
The number of transfected neurons in most of the experiments performed at 5–9 DIV (Method C) ranged from 30 to
60 neurons per 14 mm coverslip with extremes of 10 and 165 transfected neurons (Fig. 1b). In older cultures, the number
of transfected neurons decreased with culture age and ranged from 2 to 20 neurons in transfections performed at 21 DIV.
Magnetofection of 5–10 DIV neuronal cultures was extremely reliable and could be performed following any method (A, B or C)
and in cultures with different neuron densities. Methods A and B allow high efficacy of transfection and short-term protein expression
(see Fig. 2), whereas Method C is optimized for long-term expression. After establishing our techniques, we practically had no
failures in neuron transfection (more than 150 magnetofections were performed by the Medina laboratory (Methods B and C),
70 transfections by the Fritschy laboratory (Methods A and B) and more than 80 transfections by the Fuhrer laboratory (Method A)).
Magnetofection of mature neurons (414 DIV) is more delicate and requires optimization of neuronal density and regular
media exchange (Method C). Using this approach, we obtained successful transfection of 27 out of 38 cultures at 21 DIV. We
noted that all failures of neuronal magnetofection at 21 DIV were related to bad culture qualities (low neuron density or
neuronal death after media change), but never to the magnetofection procedure itself.
In all three methods, all our attempts to substitute the culture media, described in MATERIALS and PROCEDURE, with
alternative media were negative: the cellular morphology or transfection efficacy were worse.
We have, however, obtained a similar degree of neuron transfection in all our experiments performed in 5 DIV hippocampal
cultures prepared from newborn rat embryos (more than 50 magnetofections8) and in 5–10 DIV high-density cultures of cortical
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α7 nAChR-Flag PICK1-EYFP VGAT
VGAT
VGAT
VGAT
PICK1-EYFP
EYFP
EYFP
α7 nAChR-Flag
α7 nAChR-Flag
α7 nAChR-Flag
Figure 3 | Expression of PICK1 and a7 nAChR by magnetofection in cultured hippocampal GABAergic
interneurons and pyramidal cells (Method A). Cultured hippocampal cells were transfected at 12 DIV with
PICK1-EYFP or EYFP constructs and a7 nAChR-Flag constructs using magnetofection, labeled with anti-Flag
and anti-VGAT antibody and analyzed by conventional fluorescence microscopy. The panels show examples
of surface a7 nAChR staining (left), EYFP fluorescence (middle) and VGAT staining (right), VGAT being a
marker for interneurons. This was achieved in hippocampal GABAergic interneurons (top two rows) and
hippocampal pyramidal cells (bottom two rows). Neurons expressing EYFP-PICK1 or EYFP have a healthy
morphology indicating that PICK1 expression per se did not harm these cells. a7 nAChR and PICK1-EYFP
clusters are visible on the cell surface in both cell populations. Scale bar, 20 mm.
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rat neurons (n¼7). Our magnetofection
method also works efficiently in hippo-
campal and cortical cultures of embryo-
nic and newborn mice (data not shown).
Figure 2 illustrates the results of a
representative neuronal magnetofection
at 11 DIV using an EGFP vector and Method A (Table 1). Analysis at 12 DIV revealed that 8% of the neurons were transfected,
a proportion typically achieved with this protocol. More importantly, about 2% of GABAergic interneurons, a minor subpopulation
of cells in the hippocampus that can be recognized with specific neurochemical markers, were also transfected. We noticed that
GABAergic interneurons are more resistant to magnetofection than pyramidal cells and we routinely obtained 3–15 transfected
interneurons per 18 mm coverslip, thus enabling efficient analysis at the single-cell level (Fig. 3).
Recently, OZ Bioscience introduced a new improved magnetic bead-based kit (NeuroMag) for magnetofection. This novel
reagent is supposed to give higher transfection efficiency, less toxicity and does not require media change after transfection.
Application 1: GFP-gephyrin expression in young and mature neurons (Method B)
We transfected cultures with either GFP cDNAs or GFP-gephyrin cDNAs at 6 or 10 DIV and examined them at 12 DIV to determine
whether long-term expression of recombinant proteins affects neuronal growth and synapse formation. Gephyrin is a
cytoplasmic protein selectively localized in GABAergic and glycinergic postsynaptic densities11. Exogenous gephyrin was readily
detected by GFP, whereas both endogenous and exogenous gephyrin could be immunostained with antibodies for selective
detection. The results of these experiments showed that magnetofection at 6 DIV with either GFP or GFP-gephyrin did not
interfere with neuronal growth or synapse formation (Fig. 4a,b). The slow development of GABAergic synapses proceeded
normally under these circumstances. Furthermore, GFP-gephyrin was expressed at levels comparable to endogenous gephyrin,
allowing its detection at postsynaptic sites, in combination with specific markers. This result is remarkable, as gephyrin
expression appeared physiological and long-lasting and did not interfere with neural development. For transfection at 10 DIV,
Method B had to be adapted: the culture medium was exchanged 24 h before transfection with the feeding medium used for
Method C (see Table 1). The resulting morphology of the neurons was improved by this step.
Application 2: Double-magnetofection of GABAergic interneurons (Method A)
We tested whether the magnetofection method allows expression of two genes in one neuron. The proteins chosen were a7
nAChR, a nicotinic acetylcholine receptor found in many neurons throughout the CNS and particularly enriched in GABAergic
interneurons in the hippocampus, and PICK1, a protein involved in the trafficking of glutamate receptors and enriched at
glutamatergic synapses10,19,20. Our method achieved expression of these two genes in pyramidal hippocampal neurons and
even in a small subpool of cells, the hippocampal GABAergic interneurons. This is quite a remarkable achievement, considering
how hard neurons are to transfect, and considering that onlyB3% of all neurons in our cultures were GAD (glutamic acid
decarboxylase)- or VGAT (vesicular GABA transporter)-positive, thus revealing a low density of GABAergic interneurons.
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Figure 4 | GFP and GFP-gephyrin expression
in young and mature neurons (method B).
(a,b) Comparison of GABAergic synapse formation
onto a neuron transfected by magnetofection with
an EGFP cDNA at 6 DIV (a) and at 10 DIV (b) and
examined at 12 DIV (see ref. 9 for details). The
different timings of transfection did not affect
the formation of gephyrin clusters (red) apposed
to presynaptic terminals labeled for synapsin 1
(blue). (c) Expression and postsynaptic clustering
of GFP-gephyrin transfected by magnetofection at
10 DIV and examined at 12 DIV. Exogenous
GFP-gephyrin (green) was compared to the GABAA
receptor a2 subunit (red, c1) and to endogenous
gephyrin (immunostained with the monoclonal
antibody mAb7a; blue, c2). The overlay is shown
in c3. Note that GFP-gephyrin forms clusters
containing the a2 subunit (yellow in c1 and white
in c3) and intracellular aggregates (cyan in c2
and c3). It is almost completely colocalized with
endogenous gephyrin, as evidenced by the lack
of blue clusters on the transfected cell. Scale bars:
(a,b) 5 mm; (c) 20 mm.
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Figure 3 shows a selection of pictures demonstrating successful
transgene expression after magnetofection of hippocampal
GABAergic interneurons and hippocampal pyramidal cells.
Double-magnetofection was performed using a7 nAChR–Flag,
together with PICK1-EYFP or EYFP expression constructs. a7
nAChR surface cluster expression was detected using an anti-
Flag antibody, and VGAT was used as a marker for interneurons.
Application 3: shRNA magnetofection (Method C)
This method is also suitable for gene knockdown using vectors
expressing RNAi-inducing shRNAs. As an example, we
illustrate data obtained after expression in neuronal cultures
of the Lentilox 3.7 vector21 encoding shRNA against SynGAP
(sequence reported in ref.22). Lentilox 3.7 vector coexpresses
EGFP as a reporter gene and allows easy identification of the
magnetofected neurons by fluorescence microscopy (Fig. 5a).
Neurons magnetofected with SynGAP RNAi show a decreased
level of SynGAP expression 24 h after magnetofection
(Fig. 5). Three days after magnetofection and beyond (up to
6 d), clusters of SynGAP were not detectable anymore in all
magnetofected neurons.
In conclusion, magnetofection is an inexpensive and rapid method that gives successful results for young as well as mature
neurons, using different DNA or shRNA constructs, achieves long-lasting expression and even double-magnetofection of a
subpopulation of cells.
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